Apexian Therapeutics develops and commercializes novel compounds for the treatment of cancer and ocular diseases... Read more
Apexian Therapeutics develops and commercializes novel compounds for the treatment of cancer and ocular diseases... Read more
News
Jan 22, 2020
BioSpace
Apexian Pharmaceuticals: Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian Pharmaceuticals
Oct 28, 2019
Newswire
Press Release: Apexian Pharmaceuticals : APX3330 Phase I Oncology Trial Presented at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting
Jul 02, 2019
PR Newswire
Press Release: Apexian Pharmaceuticals : Apexian Pharmaceuticals' Clinical Candidate, APX3330, to Be Studied in Diabetic Models of Preleukemic Cells With Specific Mutations to Leukemia
May 31, 2019
Newswire
Press Release: Apexian Pharmaceuticals : APX3330 Phase 1 Oncology Trial Selected for ASCO Poster Presentations on June 1, 2019
Dec 19, 2018
PharmiWeb
Apexian Pharmaceuticals: Apexian Pharmaceuticals Preclinical Studies With APX3330 Shut Down Inflammatory Signaling in Leukemia
Dec 19, 2018
StreetInsider
Press Release: Apexian Pharmaceuticals : Apexian Pharmaceuticals Preclinical Studies With APX3330 Shut Down Inflammatory Signaling in Leukemia
Dec 05, 2018
BioPortfolio
Apexian Pharmaceuticals: Apexian Pharmaceuticals Presents Data on Their Lead Drug for AntiChemotherapyInduced Peripheral Neuropathy CIPN APX3330 at ASCO Palliative Care and Symptom Management Meeting
Oct 29, 2018
Business Wire
Press Release: Apexian Pharmaceuticals : NIH Awards Grant for Research on Apexian's APX3330 as Treatment for Cancer Cachexia
Sep 26, 2018
BioPortfolio
Apexian Pharmaceuticals: Apexian Chief Scientific Officer Awarded $2.3 Million National Cancer Institute Grant
Apr 25, 2018
BioPortfolio
Apexian Pharmaceuticals: Apexian Pharmaceuticals Dr. Mark Kelley Recognized as an Outstanding Researcher at Indiana UniversityPurdue University IUPUI
Apexian Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10